Read + Share
Amedeo Smart
Independent Medical Education
Narula N, Wong ECL, Dulai PS, Sengupta NK, et al. Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naive Crohn's Disease. Clin Gastroenterol Hepatol 2022;20:1579-1587.PMID: 33838348
Email
LinkedIn
Facebook
Twitter
Privacy Policy